Allergic bronchopulmonary aspergillosis (ABPA) an IgE mediated disease Full Text
Respiratory Medicine Case Reports, 05/12/2011
Schulze J et al. – The authors could demonstrate for the first time that omalizumab (OMA) completely suppresses the early allergic reaction (EAR) after bronchial allergen challenge with Aspergillus. Moreover, as has been shown by others, the patient showed a marked improvement of FEV1 without a relapse after tapering systemic steroid treatment.